Kynexis Announces Initiation of First-in-Human Phase 1
KYN-5356 is an innovative, first-in-class small molecule that targets KAT-II, a key enzyme in the kynurenine pathway Topline results are ...
Read moreKYN-5356 is an innovative, first-in-class small molecule that targets KAT-II, a key enzyme in the kynurenine pathway Topline results are ...
Read morePhase 1 clinical trial will enroll 88 healthy volunteers in the United KingdomETH47 is a first-in-class, broadly protective antiviral candidate ...
Read more-- Positive trends continue as more patients receive treatment with WU-CART-007 in this study exploring the drug’s potential in improving ...
Read moreOutstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023 aXess demonstrated exceptional patency rates ...
Read moreFirst-in-human Phase 1 study demonstrates early clinical proof of concept Positive clinical biomarker data demonstrate evidence of immune system ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.